- Home
- HLI vs RVTY Comparison
HLI vs RVTY Comparison
Compare HLI & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HLI | RVTY |
|---|---|---|
| Founded | 1972 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 11.8B |
| IPO Year | 2015 | 1994 |
Fundamental Metrics
Financial Performance| Metric | HLI | RVTY |
|---|---|---|
| Price | $142.01 | $87.80 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 15 |
| Target Price | ★ $201.14 | $113.00 |
| AVG Volume (30 Days) | 541.8K | ★ 1.0M |
| Earning Date | 05-06-2026 | 04-27-2026 |
| Dividend Yield | ★ 1.72% | 0.33% |
| EPS Growth | ★ 41.61 | N/A |
| EPS | ★ 4.74 | 2.07 |
| Revenue | $2,389,416,000.00 | ★ $3,311,822,000.00 |
| Revenue This Year | $14.44 | $6.34 |
| Revenue Next Year | $12.51 | $5.10 |
| P/E Ratio | ★ $29.47 | $41.40 |
| Revenue Growth | ★ 24.81 | N/A |
| 52 Week Low | $136.68 | $81.36 |
| 52 Week High | $211.78 | $118.30 |
Technical Indicators
Market Signals| Indicator | HLI | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 29.39 | 39.50 |
| Support Level | N/A | $83.11 |
| Resistance Level | $197.08 | $88.60 |
| Average True Range (ATR) | 3.95 | 2.81 |
| MACD | -0.29 | -0.10 |
| Stochastic Oscillator | 20.10 | 28.16 |
Price Performance
Historical ComparisonAbout HLI Houlihan Lokey Inc.
Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.